• 508 Citations
  • 10 h-Index
20052019
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 1 Similar Profiles
Magnetic Resonance Spectroscopy Medicine & Life Sciences
Gadolinium Medicine & Life Sciences
Hypertrophic Cardiomyopathy Medicine & Life Sciences
Aortic Valve Stenosis Medicine & Life Sciences
Type 2 Diabetes Mellitus Medicine & Life Sciences
Left Ventricular Hypertrophy Medicine & Life Sciences
Cardiomyopathies Medicine & Life Sciences
Perfusion Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2019

  • 508 Citations
  • 10 h-Index
  • 30 Article
  • 1 Letter

A Hyperdynamic RV Is an Early Marker of Clinical Decompensation and Cardiac Recovery in Aortic Stenosis With Normal LV Ejection Fraction

Rigolli, M., Sivalokanathan, S., Bull, S., Wijesurendra, R. S., Ariga, R., Loudon, M., Francis, J. M., Karamitsos, T. D., Neubauer, S., Mahmod, M. & Myerson, S. G., 1 Jan 2019, In : JACC: Cardiovascular Imaging. 12, 1, p. 214-216 3 p.

Research output: Contribution to journalLetter

Aortic Valve Stenosis
Biomarkers

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications

Raman, B., Ariga, R., Spartera, M., Sivalokanathan, S., Chan, K., Dass, S., Petersen, S. E., Daniels, M. J., Francis, J., Smillie, R., Lewandowski, A. J., Ohuma, E. O., Rodgers, C., Kramer, C. M., Mahmod, M., Watkins, H. & Neubauer, S., 1 Feb 2019, In : European heart journal cardiovascular Imaging. 20, 2, p. 157-167 11 p.

Research output: Contribution to journalArticle

Hypertrophic Cardiomyopathy
Gadolinium
Fibrosis
Magnetic Resonance Spectroscopy
Perfusion

Discrepancy Between Pathological Progression and Clinical Stability in a Young Patient With Hypertrophic Cardiomyopathy

Raman, B., Wen, D., Chan, K., Watkins, H., Neubauer, S. & Mahmod, M., 1 Nov 2018, In : Circulation. Cardiovascular imaging. 11, 11, p. e008154

Research output: Contribution to journalArticle

Hypertrophic Cardiomyopathy
Gadolinium
Cardiology
Natural History
Fibrosis
2 Citations

Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers

Lyon, A., Ariga, R., Mincholé, A., Mahmod, M., Ormondroyd, E., Laguna, P., de Freitas, N., Neubauer, S., Watkins, H. & Rodriguez, B., 13 Mar 2018, In : Frontiers in Physiology. 9, MAR, 213.

Research output: Contribution to journalArticle

Hypertrophic Cardiomyopathy
Electrocardiography
Phenotype
Sudden Cardiac Death
Hypertrophy

Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH)

Pouleur, A. C., Anker, S., Brito, D., Brosteanu, O., Hasenclever, D., Casadei, B., Edelmann, F., Filippatos, G., Gruson, D., Ikonomidis, I., Lhommel, R., Mahmod, M., Neubauer, S., Persu, A., Gerber, B. L., Piechnik, S., Pieske, B., Pieske-Kraigher, E., Pinto, F., Ponikowski, P. & 5 othersSenni, M., Trochu, J. N., Van Overstraeten, N., Wachter, R. & Balligand, J. L., 1 Oct 2018, In : ESC Heart Failure. 5, 5, p. 830-841 12 p.

Research output: Contribution to journalArticle

Adrenergic Agonists
Left Ventricular Hypertrophy
Heart Diseases
Randomized Controlled Trials
Placebos